Gene–gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women
Authors:
- Simona Mencej-BedračSMSimona Mencej-Bedrač
- Simona Jurković-MlakarSJSimona Jurković-Mlakar
- Janez PreželjJPJanez Preželj
- Janja MarcJMJanja Marc
- 1 January 2010
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 118 (1-2) , 102-106
Abstract
No abstract availableKeywords
Funding Information
- Ministrstvo za Izobraževanje, Znanost in Šport
This publication has 16 references indexed in Scilit:
- The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral densityJournal of Molecular Endocrinology, 2009
- Multiple Genetic Loci for Bone Mineral Density and FracturesNew England Journal of Medicine, 2008
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and DiseaseEndocrine Reviews, 2007
- Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal womenMenopause, 2007
- Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal womenOsteoporosis International, 2006
- Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in menHuman Genetics, 2005
- Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal WomenCalcified Tissue International, 2005
- NEBcutter: a program to cleave DNA with restriction enzymesNucleic Acids Research, 2003
- A New Statistical Method for Haplotype Reconstruction from Population DataThe American Journal of Human Genetics, 2001
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001